Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,236
Total Claims
$1.5M
Drug Cost
853
Beneficiaries
$1,725
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-96%
Opioid rate vs peers
0.1% vs 2.2% avg
+22%
Cost per patient vs peers
$1,725 vs $1,411 avg
+28%
Brand preference vs peers
13.7% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$70
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,520 claims · $1.2M
Generic: 9,611 claims · $245K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 322 | $322K |
| Sitagliptin Phosphate | 151 | $181K |
| Empagliflozin | 53 | $78K |
| Sacubitril/Valsartan | 65 | $77K |
| Rivaroxaban | 58 | $71K |
| Semaglutide | 33 | $48K |
| Sitagliptin Phos/Metformin Hcl | 40 | $47K |
| Dapagliflozin Propanediol | 32 | $40K |
| Dulaglutide | 14 | $28K |
| Bempedoic Acid | 30 | $28K |
| Colesevelam Hcl | 50 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 53 | $25K |
| Tirzepatide | 18 | $20K |
| Insulin Detemir | 29 | $17K |
| Linaclotide | 18 | $14K |
Prescribing Profile
Patient Profile
76
Avg Age
62%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data